Real-time enrollment status for this metastatic pancreatic adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:21 PM UTC
| NCT Number | NCT06524973 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Pancreatic Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 136 participants |
| Active Locations | 22 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | November 10, 2025 (Nov 10, 2025) |
As of July 13, 2026: Clinical trial NCT06524973 is currently recruiting participants. This clinical trial study for metastatic pancreatic adenocarcinoma is actively seeking new participants at 22 locations across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06524973 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06524973 was last updated Nov 10, 2025 (November 10, 2025). HelloStudys verifies this status automatically.